| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242720 | Academic Radiology | 2015 | 7 Pages |
Abstract
A new procedure of quantifying the hepatocyte-specific uptake of a T1-enhancing contrast agent can be used to assess impaired hepatobiliary function. The parameters obtained from perfusion MRI have the potential to predict advanced fibrosis.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Sheng MD, Yongliang MD, Lei Wang, Zhiying MD, Jie MD, Wu MD,